Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | multiple interactions | ISO | Plac1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLAC1 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | EGF protein promotes the reaction [Estradiol results in increased expression of PLAC1 mRNA] | CTD | PMID:24758408 | 17beta-estradiol | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of PLAC1 mRNA | CTD | PMID:24758408 and PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLAC1 mRNA | CTD | PMID:21296121 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLAC1 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLAC1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Plac1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLAC1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Plac1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLAC1 mRNA | CTD | PMID:17942748 | 2-hydroxypropanoic acid | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PLAC1 mRNA | CTD | PMID:30851411 | 4,4'-sulfonyldiphenol | increases expression | ISO | Plac1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of PLAC1 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | increases methylation | ISO | PLAC1 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of PLAC1 gene | CTD | PMID:31601247 | 4-nitrophenol | decreases expression | ISO | Plac1 (Mus musculus) | 6480464 | 4-nitrophenol results in decreased expression of PLAC1 mRNA | CTD | PMID:34673133 | Aflatoxin B2 alpha | increases methylation | ISO | PLAC1 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of PLAC1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of PLAC1 mRNA | CTD | PMID:23724009 | arsenous acid | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of PLAC1 mRNA | CTD | PMID:22521957 | beta-naphthoflavone | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of PLAC1 mRNA | CTD | PMID:32858204 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PLAC1 mRNA | CTD | PMID:25181051 | bisphenol A | affects expression | ISO | PLAC1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of PLAC1 mRNA | CTD | PMID:35220427 | bisphenol A | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | bisphenol A analog results in increased expression of PLAC1 mRNA | CTD | PMID:32387340 | butanal | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of PLAC1 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLAC1 mRNA | CTD | PMID:31738976 | cadmium dichloride | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLAC1 mRNA | CTD | PMID:31738976 | calcitriol | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of PLAC1 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of PLAC1 mRNA | CTD | PMID:21592394 | diarsenic trioxide | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of PLAC1 mRNA | CTD | PMID:22521957 | dorsomorphin | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of PLAC1 mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | entinostat results in increased expression of PLAC1 mRNA | CTD | PMID:26272509 and PMID:27188386 | entinostat | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAC1 mRNA | CTD | PMID:27188386 | graphite | affects expression | EXP | | 6480464 | Graphite affects the expression of PLAC1 mRNA | CTD | PMID:29933104 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PLAC1 mRNA | CTD | PMID:33387578 | pentanal | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | pentanal results in increased expression of PLAC1 mRNA | CTD | PMID:26079696 | propanal | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of PLAC1 mRNA | CTD | PMID:26079696 | rac-lactic acid | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of PLAC1 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of PLAC1 mRNA | CTD | PMID:25879800 | sotorasib | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAC1 mRNA | CTD | PMID:36139627 | sunitinib | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of PLAC1 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of PLAC1 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of PLAC1 mRNA | CTD | PMID:21592394 | titanium dioxide | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | titanium dioxide results in increased expression of PLAC1 mRNA | CTD | PMID:34973136 | trametinib | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAC1 mRNA | CTD | PMID:36139627 | trichostatin A | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of PLAC1 mRNA | CTD | PMID:24935251 | triclosan | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Triclosan results in increased expression of PLAC1 mRNA | CTD | PMID:30510588 | triptonide | increases expression | ISO | Plac1 (Mus musculus) | 6480464 | triptonide results in increased expression of PLAC1 mRNA | CTD | PMID:33045310 | urethane | decreases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Urethane results in decreased expression of PLAC1 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PLAC1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PLAC1 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLAC1 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | PLAC1 (Homo sapiens) | 6480464 | vorinostat results in increased expression of PLAC1 mRNA | CTD | PMID:27188386 | wortmannin | multiple interactions | ISO | PLAC1 (Homo sapiens) | 6480464 | wortmannin inhibits the reaction [FGF7 protein results in increased expression of PLAC1 mRNA] | CTD | PMID:15803460 | |